🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
28/11/1977 0,0113 USD
29/08/1977 0,0099 USD
31/05/1977 0,0099 USD
01/03/1977 0,0099 USD
30/11/1976 0,0099 USD
30/08/1976 0,0093 USD
01/06/1976 0,0093 USD
02/03/1976 0,0093 USD
01/12/1975 0,0093 USD
29/08/1975 0,0093 USD
02/06/1975 0,0093 USD
03/03/1975 0,0093 USD
30/08/1974 0,0093 USD
03/06/1974 0,0093 USD
04/03/1974 0,0093 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/02/1973 2,56 2,58 2,56 2,56 -0,26% 0,90% 430.099
15/02/1973 2,56 2,58 2,56 2,56 +0,26% 0,78% 547.056
14/02/1973 2,59 2,59 2,55 2,56 -1,15% 1,41% 962.064
13/02/1973 2,56 2,61 2,56 2,59 +2,09% 1,94% 1.116.749
12/02/1973 2,51 2,55 2,50 2,53 +0,92% 1,85% 969.610
09/02/1973 2,48 2,51 2,48 2,51 +2,02% 1,34% 1.158.250
08/02/1973 2,47 2,47 2,44 2,46 -0,27% 0,94% 833.789
07/02/1973 2,46 2,48 2,46 2,47 +0,67% 0,94% 1.558.166
06/02/1973 2,43 2,47 2,42 2,45 +0,82% 1,77% 1.343.117
05/02/1973 2,39 2,43 2,39 2,43 +1,95% 1,95% 1.229.933
02/02/1973 2,44 2,44 2,39 2,39 -2,17% 2,31% 2.063.722
01/02/1973 2,49 2,50 2,42 2,44 -2,13% 3,33% 977.155
31/01/1973 2,50 2,51 2,49 2,49 -0,40% 0,80% 845.107
30/01/1973 2,48 2,52 2,48 2,50 +0,80% 1,60% 1.082.794
29/01/1973 2,52 2,52 2,48 2,48 -1,96% 1,71% 728.150
26/01/1973 2,52 2,54 2,50 2,53 +0,53% 1,31% 1.497.802
24/01/1973 2,55 2,55 2,50 2,52 -1,56% 1,82% 531.965
23/01/1973 2,59 2,61 2,54 2,56 -1,28% 2,56% 796.061
22/01/1973 2,57 2,60 2,56 2,59 +0,77% 1,29% 505.555
19/01/1973 2,54 2,57 2,52 2,57 +1,04% 2,08% 1.173.341
18/01/1973 2,53 2,57 2,53 2,54 +0,39% 1,57% 630.058
17/01/1973 2,52 2,54 2,52 2,53 +0,92% 1,05% 1.135.613
16/01/1973 2,51 2,51 2,44 2,51 -0,26% 2,90% 1.312.934
15/01/1973 2,56 2,59 2,52 2,52 -1,81% 2,97% 928.109
12/01/1973 2,61 2,62 2,55 2,56 -1,65% 2,54% 1.195.978
11/01/1973 2,61 2,67 2,61 2,61 +1,68% 2,54% 2.233.498
10/01/1973 2,51 2,57 2,50 2,56 +2,24% 2,91% 1.018.656
09/01/1973 2,51 2,52 2,51 2,51 +0,13% 0,66% 1.294.070
08/01/1973 2,49 2,51 2,49 2,50 +1,07% 0,80% 931.882
05/01/1973 2,45 2,49 2,45 2,48 +1,63% 1,90% 856.426